Quisinostat

Item number	Size	Delivery time	Price
TGM-T6055-1mg	1 mg	7 - 10 business days*	55.00€
TGM-T6055-2mg	2 mg	7 - 10 business days*	77.00€
TGM-T6055-5mg	5 mg	7 - 10 business days*	125.00€
TGM-T6055-1mL	1 ml	7 - 10 business days*	140.00€
TGM-T6055-10mg	10 mg	7 - 10 business days*	223.00€
TGM-T6055-25mg	25 mg	7 - 10 business days*	348.00€
TGM-T6055-50mg	50 mg	7 - 10 business days*	448.00€
TGM-T6055-100mg	100 mg	7 - 10 business days*	638.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: Quisinostat (JNJ-26481585) (JNJ-26481585) is a novel second-generation HDAC... more

Close menu

Product information "Quisinostat"

Description: Quisinostat (JNJ-26481585) (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM, modest potent to HDACs 2, 4, 10, and 11, greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. Target: HDAC, Apoptosis, Autophagy. Smiles: Cn1cc(CNCC2CCN(CC2)c2ncc(cn2)C(=O)NO)c2ccccc12. References: Arts J, et al. JNJ-26481585, a novel "second-generation" oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Clin Cancer Res. 2009 Nov 15,15(22):6841-51.

Keywords:	JNJ-26481585
Supplier:	TargetMol
Supplier-Nr:	T6055

Properties

Application:	Antineoplastic, Histone deacetylase inhibitor
MW:	394.47 D
Formula:	C21H26N6O2

Database Information

CAS :

875320-29-9| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "Quisinostat"

Write a review